Diligent Pharma

United States - Princeton, New Jersey

• 16/05/2023
• Series A
• $8,270,000

At Diligent we connect clinical research sponsors, CROs, technology and service providers - quickly, efficiently and at very low risk. This can reduce the time taken to start clinical trials by up to 70 days.

The cloud-based Diligent Qualification Platform holds comprehensive Request For Information (RFI) details for industry suppliers around the world, as well as Vendor Qualification Assessments (VQAs) audited against latest industry standards.

This makes it easy for trial sponsors to identify and qualify relevant potential suppliers - much more quickly than by using traditional methods. It's also a great timesaver for industry suppliers as it cuts the number of RFIs to be completed and VQAs to host, while providers maintain 100% control over who sees their company information.

With the Diligent Qualification Platform, industry vendors are more visible and easily accessible to organizations actively searching for partners to conduct clinical research. Meanwhile trial sponsors can take advantage of the most recent technologies on the market with an objective selection process based on verified and up to date supplier details.

Related People

Patricia LeuchtenFounder

United States - Princeton, New Jersey

Specialties: Clinical Research, Clinical Outsourcing, Supplier Relationship Management, Client Relationship Management, Business Development, Quality and Risk Management, Organizational Change Management

LinkedIn https://www.linkedin.com/in/patricia-leuchten-8a091b5/